AlphaFold-Multimer reveals diverse cyclin-CDK substrate docking interactions
Cyclin-dependent kinases (CDKs) control eukaryotic cell-cycle progression by phosphorylating specific substrates with substrate recognition often involving cyclin-specific docking interactions. However, in minimal cell cycle control systems driven by a single cyclin-CDK complex, how docking interactions contribute to the differential timing of substrate phosphorylation remains unclear. Here, we used AlphaFold-Multimer to systematically predict interactions between the fission yeast mitotic cyclin-CDK fusion Cdc13-L-Cdc2 and its known in vivo CDK substrates. We found that many substrates are predicted to interact with the cyclin hydrophobic patch, and have identified a previously uncharacterised docking motif, [FVIPWGLAM](x)xER[LMV] (ERL motif), with features consistent with an atypical RxL motif. We show that ERL motifs can functionally substitute for canonical RxL motifs to promote phosphorylation of a model CDK substrate by Cdc13-Cdc2, while the S-phase cyclin-CDK Cig2-Cdc2 was found to preferentially phosphorylate substrates containing canonical RxL motifs. Interestingly, Cdc13-L-Cdc2 was not predicted to bind DNA replication substrates preferentially over mitotic substrates, suggesting that other mechanisms underlie the temporal ordering of CDK substrate phosphorylation. These results reveal that cyclin-CDK-substrate interactions are more diverse than previously thought.
Authors
- Nitin Kapadia (ORCID: https://orcid.org/0000-0003-4514-7631)
- Paul Nurse (ORCID: https://orcid.org/0000-0002-9244-7787)
- Sarah Willich (ORCID: https://orcid.org/0000-0001-8169-3686)
Institutions
- King's College London (GB)
- The Francis Crick Institute (GB)
- Rockefeller University (US)
Publication Details
- Journal
- Journal of Cell Science
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1242/jcs.265154
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Cancer Research UK